<DOC>
	<DOC>NCT01638923</DOC>
	<brief_summary>To evaluate efficacy and safety of a combined oral contraceptive of estradiol valerate and dienogest in the treatment of heavy menstrual bleeding</brief_summary>
	<brief_title>Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>Women 18 years or older in generally good health with a diagnosis of heavy menstrual bleeding without organic pathology, requesting contraception Willingness to use barrier contraception (e.g., condoms) from screening to study completion Willingness to use and collect sanitary protection (pads and tampons) provided by the sponsor and compatible with the alkaline hematin test throughout study completion Current diagnosis of organic uterine bleeding History of endometrial ablation, or dilatation and curettage within 2 months of Visit 1. Clinically significant pelvic findings (whether or not confirmed by transvaginal ultrasound [TVU]). Clinically significant abnormal results of breast examination (breast palpation). Positive pregnancy test at Visit 1 Less than three months since delivery, abortion, or lactation before to start Visit 1 Other contraceptive methods Any disease or condition that may worsen under hormonal treatment Smokers over the age of 35 Body mass index &gt;32</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Heavy Menstrual Bleeding</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
	<keyword>Oral contraceptive</keyword>
	<keyword>Estradiol valerate</keyword>
	<keyword>Dienogest</keyword>
</DOC>